Journal for ImmunoTherapy of Cancer Citation Rate 2026
2051-1426
BMJ
GB
Q1 Quartile Open Access Top Tier
About Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer (JIC) is a peer-reviewed academic journal covering CAR-T cell therapy research and Cancer Immunotherapy and Biomarkers, published by BMJ in GB, catalogued under ISSN 2051-1426. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 7.57 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2600 USD. OpenAlex records 5,830 works and 211,271 citations, with an h-index of 183.
Journal for ImmunoTherapy of Cancer Citation Rate 2026 — In Context
Journal for ImmunoTherapy of Cancer has a 2025 2-Year Citation Rate (OpenAlex) of 7.57, placing it in the Q1 quartile within the CAR-T cell therapy research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Journal for ImmunoTherapy of Cancer makes all articles freely available to readers for an Article Processing Charge of approximately $2600 USD.
Researchers looking to publish in Journal for ImmunoTherapy of Cancer should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Journal for ImmunoTherapy of Cancer against similar journals in the field, use our journal comparison tool.
Submission Tips for Journal for ImmunoTherapy of Cancer
- Budget $2600 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Journal for ImmunoTherapy … Compares
Compared against 57 journals in the same research areas.
| ISSN (Print) | 2051-1426 |
|---|---|
| Publisher | BMJ |
| Country | United Kingdom |
| APC / Cost | $2600 USD |
In-depth profile & metrics
Journal for ImmunoTherapy of Cancer is published by BMJ and based in United Kingdom. It publishes open access with an article-processing charge of USD 2600.
In our subject taxonomy, Journal for ImmunoTherapy of Cancer is classified under CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Immune cells in cancer.
Journal for ImmunoTherapy of Cancer is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 7.573.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Journal for ImmunoTherapy of Cancer
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 7.573 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Journal for ImmunoTherapy of … against similar publications in its field:
Related Journals in Your Field
-
Cell Reports Elsevier IF 64.50
-
Cancer Cell Elsevier IF 64.50
-
Cell Communication and Signaling Springer Nature IF 64.50
-
Immunity Cell Press IF 19.59
-
Immunological Reviews Wiley IF 8.21
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S2754803477
Get weekly updates for CAR-T cell therapy research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.